Baker Mark Robert 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Dec 26, 2012
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Purchase
Common Stock
2012-12-26$3.01/sh+1,142$3,437→ 158,014 total
Footnotes (1)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.